SEOUL, South Korea--(BUSINESS WIRE)--Feb 25, 2026--
NHN (KOSPI: 181710) (CEO: Chung Ujin), a global game developer and publisher, announced today the official global launch of 'Abyssdia,' a highly anticipated collection RPG developed by Ring Games. Now available in North America and other global markets, the game invites players into a stylized, high-stakes adventure to restore a world consumed by a mysterious dark void.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225019231/en/
Set against the backdrop of the ‘Abyss Fissure’—a phenomenon that has contaminated the world with distorted energy—Abyssdia casts players as a ‘Tuner’. As the only ones capable of recalibrating the world’s unstable frequencies, Tuners must lead a squad of elite warriors known as ‘Vanguards’ to restore balance and reclaim peace.
At the heart of Abyssdia is its Chained Action Combat, a 4-player real-time system emphasizing elemental synergies and seamless skill combinations. Success on the battlefield depends on the player’s ability to strategically pair Vanguards based on their unique weapon styles and hidden skill triggers.
Beyond the combat, the game focuses heavily on emotional immersion. Each Vanguard features a deeply personal narrative brought to life through cinematic cutscenes and character-specific musical themes. A standout feature is the ‘Let's Eat Together’ system, a high-fidelity interactive mode where players bond with their Vanguards over their favorite meals. This system replaces traditional stat-grinding with meaningful character interactions, allowing players to witness the evolving emotions and expressions of their team.
To celebrate the global debut, NHN is offering a massive rewards package for all new players. Anyone who logs in during the launch period will receive the SR-rank character ‘Elena’ for free, along with essential growth materials including 1,400 EST, 10,000 Manarings, 10 Draw Tickets, and 100 EXP Potions.
The celebration continues with a series of limited-time events designed to accelerate player progression. Through March 23, a special Global Launch Login Bonus will reward players who log in for 10 days with a total of 20 Premium Draw Tickets and 20 Draw Tickets.
Players can also dive into the ‘Endless Rabbit’ Story Quest, available until March 17, which highlights the narrative of the fan-favorite character, Rachel. By completing these dedicated story missions, players can collect exclusive event currency to exchange for premium growth materials and Vanguard Gift Boxes in the event shop.
Furthermore, a set of Progressive Missions running through May 7 will offer a steady stream of rewards, including EST, Stamina Potions, and Draw Tickets, as players reach key gameplay milestones.
Abyssdia is now available for free download on the Google Play, App Store, and Google Play Games (PC).
For more information and the latest updates, please visit the official Abyssdia website.
Official Social Media Channels
Facebook : https://www.facebook.com/ABYSSDIA/
X : https://x.com/ABYSSDIA_EN
YouTube : https://www.youtube.com/@ABYSSDIA_EN
NHN officially launches its new collection RPG, Abyssdia, featuring stylized characters and a unique Chained Action Combat system (Image: NHN)
HARARE, Zimbabwe (AP) — The United States has said it will wind down health assistance to Zimbabwe after negotiations collapsed on a U.S.-proposed funding deal that the African nation rejected in part over a requirement to share sensitive health data.
The loss of the southern African nation’s largest health donor casts uncertainty over programs to combat HIV and the public health sector in one of the world’s most vulnerable health systems, where patients often must supply even basic items such as bandages at clinics and often have to buy their own medicines due to shortfalls.
Zimbabwean authorities said the funding proposal carried conditions they could not accept. The decision was driven by concerns over data sharing concerns, fairness, sovereignty and Washington’s broader shift away from global health institutions, government spokesperson Nick Mangwana said on Wednesday.
Mangwana said the U.S. proposal was tied to “comprehensive access to Zimbabwe’s sensitive health data, including virus samples and epidemiological information from our citizens.”
He said President Emmerson Mnangagwa directed that negotiations be terminated because the U.S. was not offering a “corresponding guarantee of access to any medical innovations — such as vaccines, diagnostics, or treatments — that might result from that shared data.”
“The United States was not offering reciprocal sharing of its own epidemiological data with our health authorities,” Mangwana added. “In essence, our nation would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our people should a future health crisis emerge.”
The U.S. had offered $367 million over five years to support Zimbabwe’s priority health programs, including HIV/AIDS treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness, the U.S. embassy in Zimbabwe said.
The proposed deal would have represented the largest potential health investment in Zimbabwe by any international partner, providing “extraordinary benefits for Zimbabwean communities — especially the 1.2 million men, women, and children currently receiving HIV treatment through U.S.-supported programs,” U.S. ambassador Pamela Tremont said in a statement on Tuesday.
“We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe,” she said, adding that Zimbabwe had indicated it was prepared to continue its HIV response independently. "We wish them well,” said Tremont.
The U.S. has been Zimbabwe’s largest bilateral health donor for years, providing nearly $2 billion in assistance since 2006. The U.S. says it “is directly responsible” for Zimbabwe's success in reaching United Nations targets for HIV treatment, testing and viral load suppression.
Zimbabwe has begun rolling out lenacapavir, a long-acting HIV prevention drug administered twice a year. The rollout was supported by the United States President’s Emergency Plan for AIDS Relief, or PEPFAR, in partnership with the Global Fund, raising questions about future deliveries under the program.
Zimbabwe's College of Public Health Physicians has urged continued talks, citing the need for continued U.S funding for “critical components” of Zimbabwe’s public health system.
“An abrupt discontinuation of such support could risk treatment interruption, increased transmission, the emergence of drug resistance, and additional strain on the health system,” the college said in a statement.
Zimbabwe, like many low-income countries, has been grappling with the effects of aid reductions under President Donald Trump, although some programs continued under PEPFAR. The U.S. in January also withdrew from the World Health Organization, part of a broader reconfiguration of global health engagement.
Under the new U.S. framework, the Trump administration has pursued bilateral “America First” health funding agreements, replacing arrangements previously coordinated through the now-dismantled U.S. Agency for International Development.
The U.S. embassy in Zimbabwe said agreements worth more than $18 billion have been signed with 16 African countries, although recipient countries would contribute about $7.1 billion of this amount as part of the U.S. drive to get countries to invest more in their own health sectors.
Several countries have already entered into the new pacts. Nigeria reached an agreement emphasizing Christian-based health facilities. Rwanda and Uganda have also signed deals, while some agreements, including those with Rwanda and Côte d’Ivoire, include provisions for private U.S. sector investment.
In Kenya, a pact signed in December has been delayed after the High Court suspended implementation pending a case filed by a consumer rights group over data safety concerns.
Zimbabwean officials criticized the bilateral model as “a departure from the multilateral frameworks” and said virus data with pandemic potential should be shared exclusively through the WHO system.
“This system is designed to ensure that when a country contributes its data, the benefits — including vaccines and treatments — are shared equitably, not commercialized exclusively by those with the resources to develop them,” Mangwana said.
FILE - Zimbabwe's Minister of Health and Child Care Douglas Mombeshora holds up containers of lenacapavir, a new HIV prevention drug, during its launch in Harare, Zimbabwe, Thursday, Feb. 19, 2026. (AP Photo/Aaron Ufumeli, File)
